These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3709351)
1. Comment: Switching MAO inhibitors. True BL; Alexander B; Carter BL Drug Intell Clin Pharm; 1986 May; 20(5):384-5. PubMed ID: 3709351 [No Abstract] [Full Text] [Related]
2. Stroke resulting from a rapid switch from phenelzine to tranylcypromine. Mattes JA J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269 [No Abstract] [Full Text] [Related]
3. Switching monoamine oxidase inhibitors. True BL; Alexander B; Carter B Drug Intell Clin Pharm; 1985 Nov; 19(11):825-7. PubMed ID: 4064915 [TBL] [Abstract][Full Text] [Related]
4. Reversibility of MAO inhibition. Baxter LR J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215 [No Abstract] [Full Text] [Related]
5. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors. Durmuş B; Osse RJ; Emmer B; van Kooten F Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229 [No Abstract] [Full Text] [Related]
6. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Blackwell B; Marley E; Price J; Taylor D Br J Psychiatry; 1967 Apr; 113(497):349-65. PubMed ID: 6034391 [No Abstract] [Full Text] [Related]
7. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related]
8. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review]. García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306 [TBL] [Abstract][Full Text] [Related]
9. Intracranial haemorrhage in patients treated with monoamineoxidase inhibitors. De Villiers JC Br J Psychiatry; 1966 Feb; 112(483):109-18. PubMed ID: 5906469 [No Abstract] [Full Text] [Related]
10. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. Tulen JH; Volkers AC; van den Broek WW; Bruijn JA J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207 [No Abstract] [Full Text] [Related]
14. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. Pope HG; Jonas JM; Hudson JI; Kafka MP Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924 [TBL] [Abstract][Full Text] [Related]
15. The use of pethidine and morphine in the presence of monoamine oxidase inhibitors. Evans-Prosser CD Br J Anaesth; 1968 Apr; 40(4):279-82. PubMed ID: 5654977 [No Abstract] [Full Text] [Related]
16. Treatment of cocaine abuse with monoamine oxidase inhibitors. Brewer C Br J Psychiatry; 1993 Dec; 163():815-6. PubMed ID: 8306127 [TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study. Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898 [TBL] [Abstract][Full Text] [Related]
18. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor. Goff DC Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318 [TBL] [Abstract][Full Text] [Related]
20. Not all monoamine oxidase inhibitors are created equal. Stewart JT J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910 [No Abstract] [Full Text] [Related] [Next] [New Search]